Provided by Tiger Trade Technology Pte. Ltd.

Xenetic Biosciences Inc

2.24
0.0000
Post-market: 2.14-0.0958-4.28%18:53 EDT
Volume:43.29K
Turnover:98.17K
Market Cap:5.25M
PE:-1.88
High:2.33
Open:2.30
Low:2.11
Close:2.24
52wk High:13.93
52wk Low:1.87
Shares:2.34M
Float Shares:1.95M
Volume Ratio:1.50
T/O Rate:2.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1900
EPS(LYR):-1.5800
ROE:-47.04%
ROA:-26.80%
PB:0.86
PE(LYR):-1.42

Loading ...

May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 26, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Mar 21, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 18, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 12, 2024

Major Issues Report

Form 8-K - Current report
Dec 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 18, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 11, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 15, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2023

Major Issues Report

8-K - Current report
Apr 28, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 23, 2023

Major Issues Report

8-K - Current report